GL1X · GenesisL1 explorer

Research workbench

Structure of human mcl-1 in complex with indole acid inhibitor

Analyse Structure of human mcl-1 in complex with indole acid inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6QFQ
Type
protein
Length
150 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Induced myeloid leukemia cell differentiation protein mcl- 1
UniProt
Q07820
Ligands
J3E
Pockets
1 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 79% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInduced myeloid leukemia cell differentiation protein mcl- 1protein15079% helix, 0% strandQ07820

Ligands and binding sites

  • J3E · 7-(3,5-dimethyl-1~{H}-pyrazol-4-yl)-3-(3-naphthalen-1-yloxypropyl)-1~{H}-indole-2-carboxylic acid · ligand · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11870.630.8318J3E

Compared structures

  • 6QFQ · Structure of human Mcl-1 in complex with indole acid inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.